GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Deferred Policy Acquisition Costs

Pangen Biotech (XKRX:222110) Deferred Policy Acquisition Costs


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Pangen Biotech (XKRX:222110) Business Description

Industry
Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.